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Financing Patient Education in Arthritis and 
Musculoskeletal and Skin Diseases 
Jean Goeppinger and Jane Walter 
On March 23-24, 1989, a conference, Financing 
Patient Education in Arthritis and Musculoskeletal 
and Skin Diseases, was held in Atlanta, Georgia. 
This conference was sponsored by the National 
Arthritis Advisory Board (NAAB). It recognized the 
significant progress that has been made in es- 
tablishing the effectiveness of arthritis patient edu- 
cation since the first NAAB-sponsored conference, 
which focused on patient education, was held in 
1980 (Arthritis Research and Education in Nursing 
and Allied Health) and supported today’s needs to 
establish the cost-effectiveness of arthritis patient 
education and secure adequate reimbursement for 
structured educational efforts. Speakers and partici- 
pants reflected the diverse constituencies of patient 
education: health education researchers; health care 
professionals, including physicians, health educa- 
tors, nurses, and allied health professionals; repre- 
sentatives of federal and private health insurance 
organizations; representatives of the Arthritis Foun- 
dation and the National Psoriasis Foundation; mem- 
bers of federal advisory bodies such as the National 
Arthritis Advisory Board; persons with arthritis, 
musculoskeletal, and skin diseases; and social and 
behavioral scientists. 
The opening presentations, by Drs. Halsted 
Holman (“Why Patient Education?”), Steven Maz- 
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zuca (“Does Patient Education in Chronic Disease 
Have Therapeutic Value?”), and Lawren Daltroy 
(“Critical Summary of the Field”), built a convincing 
argument for the effectiveness of arthritis patient 
education in improving commonly accepted clinical 
outcome measures, e g ,  pain, dysfunction and disa- 
bility, and depression. Dr. Kate Lorig (“Does Patient 
Education Require a Prescription?”) added another 
perspective to the argument, that of health education 
as a right, a consumer-driven health care demand 
rather than a physician-controlled component of 
medical treatment. 
The opening speakers were followed by panel 
discussions of the barriers to reimbursement existing 
within (1) Federal health programs, e.g., the prospec- 
tive payment and resource-based relative value sys- 
tems, (2) Federally funded health insurance pro- 
grams such as Medicare, and (3) the private 
insurance industry. Representatives from the private 
sector stressed that health insurance most readily 
reimburses for random, unexpected events rather 
than the predictable, persistent problems associated 
with chronic disease (Louis Sapparito) and that the 
efficacy of patient education must be firmly es- 
tablished and clearly articulated (Dr. Halley Faust). 
In conclusion, a series of case studies were pre- 
sented that documented successful arthritis educa- 
tion efforts in a variety of settings despite the bar- 
riers. Janice Smith-Pigg described an ambulatory 
comprehensive arthritis program in a private hospi- 
tal. Patient education is provided as part of this 
program and is, to some extent, reimbursed. Dr. 
Wendy Cuneo described how the equality of patient 
education was assured in a large health maintenance 
organization. Suzanne Koebel and Marsha Dubbert 
described state-supported arthritis programs in Ohio 
and Missouri, respectively. Nina Berlin outlined an 
action model for securing reimbursement, based on 
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successful experiences in diabetes patient edu- 
cation. 
The remainder of this summary highlights the 
major issues identified at the conference and con- 
cludes with a set of recommendations for action 
developed at two post-conference sessions, one 
chaired by Dr. Sam Brown and organized by the 
NAAB and the other organized and chaired by Dr. 
John Winfield for the American College of Rheuma- 
tology. Representatives of the Arthritis Health Pro- 
fessions Association, the Arthritis Foundation, the 
National Arthritis Advisory Board, and some confer- 
ence participants attended. 
THE ISSUES 
Although the effectiveness of arthritis patient edu- 
cation in improving commonly accepted clinical 
measures has been rather consistently demonstrated, 
several issues remain to be addressed before the 
argument is sufficiently convincing to permit reim- 
bursement for patient education. These issues in- 
clude the lack of evidence regarding the effect of 
patient education on health services utilization. Dr. 
Holman and his research colleagues at Stanford have 
demonstrated that 4 years after 233 elderly persons 
took the Arthritis Self-Help course, 34% had fewer 
visits to the physician than prior to course participa- 
tion. Attempts to replicate these findings have not 
been made, however, and, more importantly, the 
essential cost-benefit and cost-effectiveness studies 
have not been conducted. 
Another issue raised is that few studies have 
demonstrated the extent to which the findings from 
relatively well-controlled research experiments can 
be replicated in generally uncontrolled service set- 
tings. Dissemination efforts have occurred but have 
not been carefully monitored; process and outcome 
evaluations of the service-based replications of ex- 
perimental research protocols need to be conducted. 
Such studies are not highly valued by the scientific 
community and are not well funded; they are, 
however, essential to building the case for reim- 
bursement. 
Three, the effects of patient education efforts in 
musculoskeletal and skin diseases other than arth- 
ritis have not been examined; the work done in 
patient education of persons with osteoarthritis, 
rheumatoid arthritis, and low back pain, however, 
can be instructive (Daltroy). A set of clinical parame- 
ters must be identified as acceptable outcome mea- 
sures; patient education interventions need to be 
developed; carefully controlled research trials need 
to be conducted; and cost-benefit and cost-effec- 
tiveness studies need to be planned. 
Four, the impact of reimbursing professionally led 
patient education interventions on volunteer, mu- 
tual aid approaches to health education must be 
considered so that disincentives are not uninten- 
tionally created (Barbara Giloth). The relative contri- 
butions of health education that is patient-oriented 
and professionally provided and health education 
that is community-based and lay-led must be con- 
sidered. 
Finally, we must consider the issue of whether 
patient education is simply a physician’s duty, to be 
reimbursed accordingly, or whether structured 
health education is to be offered and reimbursed as 
part of a multidisciplinary approach to the care of 
persons with arthritis, musculoskeletal, and skin 
diseases. 
The first four issues can be resolved largely 
through the continued development, testing, dis- 
semination, and evaluation of education interven- 
tions for persons with arthritis, musculoskeletal, and 
skin diseases. The last issue, on the other hand, 
suggests that plans must be developed to ensure the 
consistent provision and quality of education inter- 
ventions and to obtain third-party reimbursement. 
Work on these issues can proceed concurrently, with 
researchers assuming major responsibility for ad- 
vancing the science of patient/health education and 
clinicians, patients, and their advocates, and volun- 
tary organizations assuming responsibility for in- 
fluencing policy development. The remainder of the 
meeting and the postconference sessions empha- 
sized steps necessary to the development of ade- 
quate financing mechanisms. 
Dr. Cuneo stated that to engage in quality assu- 
rance efforts, we need to know the following: what is 
most important to the patient education program and 
to the sponsoring organization; the acceptable indi- 
cators, outcomes, and/or standards of successful 
patient education; the extent to which variability 
around the standards will be tolerated; how to incor- 
porate peer review; and how to document and report 
findings. Ms. Berlin illustrated such activities in the 
effort she led on behalf of the National Diabetes 
Advisory Board to secure reimbursement for dia- 
betes patient education that was initiated in the late 
1970s. The National Diabetes Advisory Board began 
by developing consensus papers on the treatment of 
five complications of diabetes and identifying stan- 
dards for acceptable diabetes education programs. 
She stressed the importance of becoming acquainted 
with the health care financing system(s) and the 
locus of decision-making; working with, not legislat- 
82 Goeppinger and Walter Vol. 2, No. 2, June 1989 
ing against, third-party insurers; learning to market 
education programs; and learning to negotiate with 
insurers on a case-by-case basis. 
RECOMMENDATIONS 
These comments guided participants in the postcon- 
ference sessions to develop the following recom- 
mendations for actions designed to secure reim- 
bursement for arthritis patient education: 
1. Designate a representative national organization 
or coalition to assume leadership in developing 
reimbursement for arthritis patient education. 
2. Establish standards for structured arthritis patient 
education programs. 
3. Evaluate the cost-effectiveness of arthritis patient 
education. 
4. Obtain financial reimbursement by successful 
marketing and negotiation with representatives of 
health insurance organizations and federal and 
state health policymakers. 
On April 17, 1989, the NAAB agreed to act as the 
catalyst for these efforts. The Board plans to propose 
a process for developing standards for patient educa- 
tion in arthritis, musculoskeletal, and skin diseases. 
The proposal will be discussed, modified, and ap- 
proved at a NAAB-initiated meeting of representa- 
tives from relevant professional and voluntary orga- 
nizations and successful state-wide programs. 
Responsibility for implementing the process of stan- 
dard development will then be assumed by partici- 
pating organizations; the NAAB will continue to be 
involved in a coordinating role. The NAAB intends 
that this process will ensure that progress achieved 
during the 1970s and 1980s will be utilized in the 
1990s to secure improved financing for patient edu- 
cation in arthritis, musculoskeletal, and skin dis- 
eases. 
